ESC 365 - Risk of incident atherosclerotic cardiovascular disease events by atherogenic lipid levels in a real-world population of 62,428 on-statin individuals with diabetes

ESC Premium Access

Risk of incident atherosclerotic cardiovascular disease events by atherogenic lipid levels in a real-world population of 62,428 on-statin individuals with diabetes

Session: Lipid lowering therapy in primary cardiovascular prevention

Topic: Lipids (Epidemiology and Prevention)

Speaker: Doctor J. Rana (Oakland, US)

Event: ESC Congress 2017

Congress Presentation

Add to my library

About the speaker

Doctor Jamal Rana

Kaiser Permanente Oakland Medical Centre, Oakland (United States of America)

0 follower

8 more presentations in this session

Assessing gaps in cholesterol treatment guidelines for primary prevention of cardiovascular disease using clinical trial evidence: results from the prospective population-based Rotterdam Study

Speaker: Doctor M. Leening (Rotterdam, NL)

Effects of morning versus evening statin therapy on lipid profile: A systematic review and meta-analysis

Speaker: Doctor P. Penson (Liverpool, GB)

Familial hypercholesterolemia: development of a next generation sequencing approach to the disease

Speaker: Associate Professor R. Marcucci (Florence, IT)

Comprehensive genotyping and phenotyping in patients with severe hypercholesterolemia

Speaker: Doctor H. Tada (Kanazawa, JP)

Elevated circulating PCSK9 concentrations predict subclinical atherosclerotic and metabolic changes in low risk obese and non-obese patients

Speaker: Doctor T. Stefan (Kosice, SK)

Access the full session

Lipid lowering therapy in primary cardiovascular prevention

Speakers: Doctor J. Rana, Doctor M. Leening, Doctor P. Penson, Associate Professor R. Marcucci, Doctor H. Tada...

About the event

ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources